ABCB5+ Limbal Epithelial Stem Cells Inhibit Developmental but Promote Inflammatory (Lymph) Angiogenesis While Preventing Corneal Inflammation
Cells · 2023
DOI: 10.3390/cells12131731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Berbang Meshko und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Cologne, 50937 Cologne, Germany. Hauptthemen laut MEDLINE: Corneal Neovascularization, Limbus Corneae, Keratitis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIA NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
The limbus, the vascularized junction between the cornea and conjunctiva, is thought to function as a barrier against corneal neovascularization. However, the exact mechanisms regulating this remain unknown. In this study, the limbal epithelial stem cell (LESC) marker ABCB5 was used to investigate the role of LESCs in corneal neovascularization. In an ABCB5KO model, a mild but significant increase of limbal lymphatic and blood vascular network complexity was observed in developing mice (4 weeks) but not in adult mice. Conversely, when using a cornea suture model, the WT animals exhibited a mild but significant increase in the number of lymphatic vessel sprouts compared to the ABCB5KO, suggesting a contextual anti-lymphangiogenic effect of ABCB5 on the limbal vasculature during development, but a pro-lymphangiogenic effect under inflammatory challenge in adulthood. In addition, conditioned media from ABCB5-positive cultured human limbal epithelial cells (ABCB5+) stimulated human blood and lymphatic endothelial cell proliferation and migration. Finally, a proteomic analysis demonstrated ABCB5+ cells have a pro(lymph)angiogenic as well as an anti-inflammatory profile. These data suggest a novel dual, context-dependent role of ABCB5+ LESCs, inhibiting developmental but promoting inflammatory (lymph)angiogenesis in adulthood and exerting anti-inflammatory effects. These findings are of high clinical relevance in relation to LESC therapy against blindness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, University of Cologne, 50937 Cologne, Germany.
- TICEBA GmbH, Im Neuenheimer Feld 517, 69120 Heidelberg, Germany.
- RHEACELL GmbH & Co. KG, Im Neuenheimer Feld 517, 69120 Heidelberg, Germany.
- Transplant Research Program, Boston Children's Hospital, Boston, MA 02115, USA.
- Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Boston, MA 02115, USA.
- Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.
ORCID-Profile: Berbang Meshko, Thomas L A Volatier, Karina Hadrian, Mark Andreas Kluth, Markus H Frank, Claus Cursiefen
Förderung
- NEI NIH HHS
- NIA NIH HHS
- NHLBI NIH HHS
- EU COST CA18116
- EU Horizon 2020 Arrest Blindness
Zitieren
APA
Meshko, B., Volatier, T. L. A., Hadrian, K., Deng, S., Hou, Y., Kluth, M. A., Ganss, C., Frank, M. H., Frank, N. Y., Ksander, B., Cursiefen, C., & Notara, M. (2023). ABCB5+ Limbal Epithelial Stem Cells Inhibit Developmental but Promote Inflammatory (Lymph) Angiogenesis While Preventing Corneal Inflammation. Cells. https://doi.org/10.3390/cells12131731
Vancouver
Meshko B, Volatier TLA, Hadrian K, Deng S, Hou Y, Kluth MA, et al. ABCB5+ Limbal Epithelial Stem Cells Inhibit Developmental but Promote Inflammatory (Lymph) Angiogenesis While Preventing Corneal Inflammation. Cells. 2023. doi:10.3390/cells12131731
BibTeX
@article{Meshko2023,
author = {Meshko, Berbang and Volatier, Thomas L A and Hadrian, Karina and Deng, Shuya and Hou, Yanhong and Kluth, Mark Andreas and Ganss, Christoph and Frank, Markus H and Frank, Natasha Y and Ksander, Bruce and Cursiefen, Claus and Notara, Maria},
title = {ABCB5+ Limbal Epithelial Stem Cells Inhibit Developmental but Promote Inflammatory (Lymph) Angiogenesis While Preventing Corneal Inflammation},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12131731}
}
EUVIMED